Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs

Molecular Therapy

Volumn 21, Issue 2, 2013, Pages 388-398

  Chung, Arthur C K ^a,b   Dong, Yuan ^a   Yang, Weiqin ^b   Zhong, Xiang ^a,b   Li, Rong ^a,b,c   Lan, Hui Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c First Hospital of Yunnan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; FIBRONECTIN; MICRORNA 192; MICRORNA 21; MICRORNA 29B; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE THERAPY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; MALE; MOUSE; NONHUMAN; OBSTRUCTIVE NEPHROPATHY; OBSTRUCTIVE UROPATHY; RAT; RENAL PROTECTION; SMAD7 GENE;

MUS;

EID: 84873406358     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.251     Document Type: Article

References (36)

1. Pohlers, D, Brenmoehl, J, Löffer, I, Müller, CK, Leipner, C, Schultze-Mosgau, S et al. (2009). TGF-β and fbrosis in different organs-molecular pathway imprints. Biochim Biophys Acta 1792: 746-756.
2. Stahl, PJ and Felsen, D (2001). Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fbrosis in kidney disease. Am J Pathol 159: 1187-1192.
3. Iwano, M and Neilson, EG (2004). Mechanisms of tubulointerstitial fbrosis. Curr Opin Nephrol Hypertens 13: 279-284.
4. Roberts, AB (1998). Molecular and cell biology of TGF-β. Miner Electrolyte Metab 24: 111-119.
5. Hoffman, BB, Sharma, K and Ziyadeh, FN (1998). Potential role of TGF-β in diabetic nephropathy. Miner Electrolyte Metab 24: 190-196.
6. Schnaper, HW, Hayashida, T, Hubchak, SC and Poncelet, AC (2003). TGF-β signal transduction and mesangial cell fbrogenesis. Am J Physiol Renal Physiol 284: F243-F252.
7. Meng, XM, Huang, XR, Xiao, J, Chen, HY, Zhong, X, Chung, AC et al. (2012). Diverse roles of TGF-β receptor II in renal fbrosis and infammation in vivo and in vitro. J Pathol 227: 175-188.
8. Lan, HY and Chung, AC (2011). Transforming growth factor-β and Smads. Contrib Nephrol 170: 75-82.
9. Meng, XM, Huang, XR, Xiao, J, Chung, AC, Qin, W, Chen, HY et al. (2012). Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal infammation and fbrosis in vivo and in vitro. Kidney Int 81: 266-279.
10. Ka, SM, Huang, XR, Lan, HY, Tsai, PY, Yang, SM, Shui, HA et al. (2007). Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice. J Am Soc Nephrol 18: 1777-1788.
11. Lan, HY, Mu, W, Tomita, N, Huang, XR, Li, JH, Zhu, HJ et al. (2003). Inhibition of renal fbrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 14: 1535-1548.
12. Ng, YY, Hou, CC, Wang, W, Huang, XR and Lan, HY (2005). Blockade of NFkappaB activation and renal infammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl 67: S83-S91.
13. Hou, CC, Wang, W, Huang, XR, Fu, P, Chen, TH, Sheikh-Hamad, D et al. (2005). Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fbrosis in rat remnant kidney. Am J Pathol 166: 761-771.
14. Chen, HY, Huang, XR, Wang, W, Li, JH, Heuchel, RL, Chung, AC et al. (2011). The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 60: 590-601.
15. Zhong, X, Chung, AC, Chen, HY, Meng, XM and Lan, HY (2011). Smad3-mediated upregulation of miR-21 promotes renal fbrosis. J Am Soc Nephrol 22: 1668-1681.
16. Qin, W, Chung, AC, Huang, XR, Meng, XM, Hui, DS, Yu, CM et al. (2011). TGF-β/Smad3 signaling promotes renal fbrosis by inhibiting miR-29. J Am Soc Nephrol 22: 1462-1474.
17. Lan, HY (2011). Diverse roles of TGF-β/Smads in renal fbrosis and infammation. Int J Biol Sci 7: 1056-1067.
18. Chung, AC, Huang, XR, Meng, X and Lan, HY (2010). miR-192 mediates TGF-β/Smad3-driven renal fbrosis. J Am Soc Nephrol 21: 1317-1325.
19. Li, JH, Zhu, HJ, Huang, XR, Lai, KN, Johnson, RJ and Lan, HY (2002). Smad7 inhibits fbrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13: 1464-1472.
20. Chung, AC, Zhang, H, Kong, YZ, Tan, JJ, Huang, XR, Kopp, JB et al. (2010). Advanced glycation end-products induce tubular CTGF via TGF-β-independent Smad3 signaling. J Am Soc Nephrol 21: 249-260.
21. Yang, F, Chung, AC, Huang, XR and Lan, HY (2009). Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and-independent Smad pathways: the role of Smad3. Hypertension 54: 877-884.
22. Yang, F, Huang, XR, Chung, AC, Hou, CC, Lai, KN and Lan, HY (2010). Essential role for Smad3 in angiotensin II-induced tubular epithelial- mesenchymal transition. J Pathol 221: 390-401.
23. Huang, XR, Chung, AC, Wang, XJ, Lai, KN and Lan, HY (2008). Mice overexpressing latent TGF-β1 are protected against renal fbrosis in obstructive kidney disease. Am J Physiol Renal Physiol 295: F118-F127.
24. Huang, XR, Chung, AC, Zhou, L, Wang, XJ and Lan, HY (2008). Latent TGF-β1 protects against crescentic glomerulonephritis. J Am Soc Nephrol 19: 233-242.
25. Chen, K, Chen, J, Li, D, Zhang, X and Mehta, JL (2004). Angiotensin II regulation of collagen type I expression in cardiac fbroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44: 655-661.
26. Huang, XR, Chung, AC, Yang, F, Yue, W, Deng, C, Lau, CP et al. (2010). Smad3 mediates cardiac infammation and fbrosis in angiotensin II-induced hypertensive cardiac remodeling. Hypertension 55: 1165-1171.
27. Chung, AC, Huang, XR, Zhou, L, Heuchel, R, Lai, KN and Lan, HY (2009). Disruption of the Smad7 gene promotes renal fbrosis and infammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 24: 1443-1454.
28. Chung, AC and Lan, HY (2011). Chemokines in renal injury. J Am Soc Nephrol 22: 802-809.
29. Verrecchia, F, Chu, ML and Mauviel, A (2001). Identifcation of novel TGF-β/Smad gene targets in dermal fbroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276: 17058-17062.
30. van Rooij, E, Sutherland, LB, Thatcher, JE, DiMaio, JM, Naseem, RH, Marshall, WS et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fbrosis. Proc Natl Acad Sci USA 105: 13027-13032.
31. Kato, M, Zhang, J, Wang, M, Lanting, L, Yuan, H, Rossi, JJ et al. (2007). MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104: 3432-3437.
32. Liu, G, Friggeri, A, Yang, Y, Milosevic, J, Ding, Q, Thannickal, VJ et al. (2010). miR-21 mediates fbrogenic activation of pulmonary fbroblasts and lung fbrosis. J Exp Med 207: 1589-1597.
33. Kantharidis, P, Wang, B, Carew, RM and Lan, HY (2011). Diabetes complications: the microRNA perspective. Diabetes 60: 1832-1837.
34. Li, R, Rosendahl, A, Brodin, G, Cheng, AM, Ahgren, A, Sundquist, C et al. (2006). Deletion of exon I of SMAD7 in mice results in altered B cell responses. J Immunol 176: 6777-6784.
35. Li, JH, Huang, XR, Zhu, HJ, Oldfeld, M, Cooper, M, Truong, LD et al. (2004). Advanced glycation end products activate Smad signaling via TGF-β-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J 18: 176-178.
36. Kloosterman, WP, Wienholds, E, de Bruijn, E, Kauppinen, S and Plasterk, RH (2006). In situ detection of miRNAs in animal embryos using LNA-modifed oligonucleotide probes. Nat Methods 3: 27-29.